Bernstein Liebhard LLP

Home » Trasylol » Trasylol Lawsuits

Trasylol Lawsuits

To date, Bayer HealthCare Pharmaceuticals Inc. has been hit with 78 lawsuits over its drug Trasylol, which is given during heart surgery to control bleeding. The Trasylol lawsuits allege that Bayer is liable for manufacturing and failing to warn Trasylol users of its dangerous side effects. Clinical studies dating back several years show an increased risk for kidney failure, strokes, and heart attacks among Trasylol users.

Trasylol 60 Minutes Report: 60 Minutes Video Report Related Topics: Trasylol Trasylol Heart Attacks Trasylol Kidney Failure Trasylol Stroke Dangerous Drug Alert: FDA Orders Bayer to Remove Trasylol from the Market Other Trasylol News: Recently Recalled Trasylol Blamed for 1,000 Deaths a Month Trasylol Named in 78 Lawsuits Information About Trasylol (Aprotinin) Being Linked to Tens of Thousands of Deaths Research Articles: FDA Issues Public Health Advisory for Trasylol FDA Revises Labeling for Trasylol FDA Issues Early Communication About Ongoing Safety Review of Aprotinin Injection FDA Requests Marketing Suspension of Trasylol 1000 Lives a Month

Additionally, the Trasylol lawsuits allege that Bayer knew Trasylol increases patients’ risk of death, but the drug company failed to disclose its knowledge to the FDA. Lawsuits also note that a Bayer study looked at more than 78,000 patients from January 2003 through March 2006. In that study, researchers concluded that Trasylol users have a 64% higher risk of death than those who took a similar alternate drug. The lawsuits highlight that Bayer did not publicize this study or notify the FDA.

The lawsuits further allege that in January 2006, a study was published in the New England Journal of Medicine that concluded Trasylol use doubled kidney failure risks, increased heart attack risks by 50%, and increased stroke risks by 182%, compared to alternative drug use. After this study, Bayer still refused to pull Trasylol off the market until November 2007. In February 2008, Dr. Mangano, the author of the January 2006 Trasylol study, told “60 minutes” that if Bayer had removed the drug immediately after his study was published, approximately 431,000 patients would not have used the drug and 22,000 lives would have been saved.

Do You Qualify for a Trasylol Lawsuit?

If you or a family member received Trasylol during heart surgery and suffered a serious side effect, such as kidney failure, heart attack, or stroke, our Trasylol lawyers can help you seek compensation for your injuries by filing a medical malpractice lawsuit on your behalf. With a Trasylol lawsuit, you may be eligible to collect compensation for:

• medical bills
• lost income
• pain and suffering
• mental anguish
• more

Contact us today to find out if you qualify for a Trasylol lawsuit.